Introduction {#sec0005}
============

*Listeria monocytogenes* is a gram-positive bacillus causing human infection. The lethality is up to 30% in patients with neurological involvement. The central nervous system (CNS) involvement includes meningitis and encephalitis, often affecting people at extreme ages, pregnant women, diabetic and immunocompromised patients \[[@bib0005],[@bib0010]\]. We present two patients with *L. monocytogenes* meningitis who developed non-obstructive hydrocephalus early in the course of their disease.

Patient 1- A-72-year-old man was evaluated because of fever and generalized weakness of two days, accompanied by a sub-acute weight loss and abdominal lymphadenopathy. Laboratory studies showed pancytopenia and elevated LDH. Because of a possible infection, empirical intravenous ceftriaxone and ciprofloxacin was initiated. Bone marrow biopsy showed infiltration by diffuse large B-cell lymphoma. Within a day, the patient became confused and developed nuchal rigidity without focal neurological deficit or papilledema. Brain computerized tomography (CT) demonstrated normal-sized ventricles ([Fig. 1](#fig0005){ref-type="fig"}a). Lumbar puncture performed at that stage showed a traumatically bloody CSF with elevated protein of 942 g/dL, low glucose of 16 mg/dL and negative culture, probably due to partial treatment with antimicrobials. Intravenous ampicillin was added for possible *L. monocytogenes*. Because of further deterioration, magnetic resonance imaging (MRI) was performed four days later and demonstrated marked non-obstructive ventricular dilatation without mass effect or hemorrhage ([Fig. 1](#fig0005){ref-type="fig"}b-c). Surgical ventriculostomy was performed and CSF assayed for a 16S ribosomal RNA (rRNA) gene by PCR (polymerase chain reaction) indicated the presence of *L. monocytogenes*. After a 21-day course of ampicillin there was significant clinical and neurological improvement.Fig. 1Imaging studies of patient 1. (a) Non-contrast computed tomography showing normal ventricular size. (b) MRI performed 4 days later: T2 and FLAIR: Enlargement of the lateral and third ventricles with periventricular trans ependymal CSF edema. MRI- magnetic resonance imaging, CSF-Cerebro-spinal fluid.Fig. 1

Patient 2-A-56-year-old man with metastatic lung adenocarcinoma was admitted because of low-grade fever and somnolence of two days duration. Because meningitis was not suspected at that time, intravenous ceftriaxone and ciprofloxacin were initiated for possible systemic infection. Two days later blood cultures yielded *L. monocytogenes* and ampicillin was added. Further clinical deterioration prompted a head CT showing a non-obstructive ventriculomegaly, new comparing to an MRI performed one month earlier. Despite treatment, his condition deteriorated and, according to his request, no life-saving measures were undertaken.

At the time of writing this case report both patients had passed away, so an informed consent was not applicable.

Discussion {#sec0010}
==========

The two patients manifested fever and a rapidly progressive neurological deterioration caused by *L. monocytogenes*. Both developed non-obstructive hydrocephalus early during the course of their disease. Meningitis in patient 1 was documented by a PCR-based CSF analysis, two days after initiation of treatment. Although no CSF testing was performed in patient 2, positive blood culture and the clinical course are highly suggestive of *L. monocytogenes* meningitis.

Hydrocephalus is a severe complication of bacterial meningitis, likely related to defective CSF resorption through arachnoid granulations because of severe inflammatory reaction \[[@bib0015]\]. Although it is common in subacute and chronic tuberculous or fungal meningitis, it also occurs in about 5% of adult patients with acute community-acquired meningitis and represents an independent unfavorable risk factor \[[@bib0015]\]. *S. pneumoniae* is the predominant and *L. monocytogenes* is the second most common pathogen causing hydrocephalus, which develops in up to 14% of patients with *L. monocytogenes,* mostly with symptom duration longer than for 4 days.

Reviewing the literature, it is of note that early hydrocephalus develops several days after presentation, particularly in patients inadequately covered for *L. monocytogenes* from the beginning ([Table 1](#tbl0005){ref-type="table"}) \[[@bib0010],[@bib0020], [@bib0025], [@bib0030], [@bib0035], [@bib0040]\]. After neurological deterioration, hydrocephalus is diagnosed by imaging and ventriculostomy is usually performed for the decompression, resulting in gradual neurological improvement with mild residual cognitive impairment.Table 1Summary of reviewed cases. AM-antimicrobials AG-aminoglycosides.Table 1PatientAgeMedical backgroundImmunosupressionInitial treatmentTime interval to adequate AM tx (days)TreatmentOutcomeReference17NoneNot knownCeftriaxone, Vancomycin4Ampicillin, VentriculostomyGood\[[@bib0035]\]27mNoneNot knownCeftriaxone6AmpicillinGood\[[@bib0040]\]362Gastric cancerNot knownCeftriaxone, Vancomycin8Ampicillin, AG VentriculostomyConfusion\[[@bib0030]\]475UCSteroids, 6 M P, anti-TNFMeropenem2Meropenem, VentriculostomyGood\[[@bib0025]\]510NoneNot knownCefotaxime7Amikacin, Rifampin, VentriculostomyGood\[[@bib0020]\]63.5NoneNot knownCefotaxime5Ampicillin, AGDeath\[[@bib0020]\]76.5NoneNot knownCefotaxime, Amikacin4Ampicillin, VentriculostomyDeath\[[@bib0020]\]847Breast adenocarcinomaChemotherapyAmpicilin1AmpicillinGood\[[@bib0010]\]972LymphomaPancytopeniaCeftriaxone, Ciprofolxacin3Meropenem, VentriculostomyGoodPatient 11056Lung carcinomaChemotherapyCeftriaxone, Ciprofolxacin4AmpicillinDeathPatient 2

Our presentation emphasizes the importance of early non-obstructive hydrocephalus in *L. monocytogenes* meningitis. Hydrocephalus must be suspected in patients with neurological deterioration few days after the initial presentation, particularly when the treatment did not include antibacterial coverage against *L. monocytogenes*.
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